Sphingolipid-Enriched Extracellular Vesicles and Alzheimer’s Disease: A Decade of Research
Year: 2016
Type: review
Abstract: Extracellular vesicles (EVs), particularly exosomes, have emerged in the last 10 years as a new player in the progression of Alzheimer's disease (AD) with high potential for being useful as a diagnostic and treatment tool. Exosomes and other EVs are enriched with the sphingolipid ceramide as well as other more complex glycosphingolipids such as gangliosides. At least a subpopulation of exosomes requires neutral sphingomyelinase activity for their biogenesis and secretion. As ceramide is often elevated in AD, exosome secretion may be affected as well. Here, we review the available data showing that exosomes regulate the aggregation and clearance of amyloid-beta (Aβ) and discuss the differences in data from laboratories regarding Aβ binding, induction of aggregation, and glial clearance. We also summarize available data on the role of exosomes in extracellular tau propagation, AD-related exosomal mRNA/miRNA cargo, and the use of exosomes as biomarker and gene therapy vehicles for diagnosis and potential treatment.
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-160567
Institution: Augusta University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: extracellular vesicles, exosomes
Open Access status: green
OpenAlex ID: W2523456649
